Petros Tsantoulis

20PUBLICATIONS
214CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Tumour immunologyPredictive and prognostic markersHaematological tumoursMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (20)

|May 29, 2026
Addition of Intravesical Recombinant Bacillus Calmette-Guérin to Perioperative Chemoimmunotherapy in Muscle-Invasive Bladder Cancer: Primary Analysis of the Single-Arm Phase II Trial SAKK 06/19.

|Feb 21, 2026
Mast-cell derived nerve growth factor drives ILC2 pro-tumoral functions in bladder cancer.

Maryline Falquet, Hajar El Ahanidi, Alejandra Gomez-Cadena

|Nov 22, 2025
A robust classifier for the intrinsic consensus molecular subtypes in colorectal cancer.

Petros Tsantoulis, Yourae Hong, Pratyaksha Wirapati

|Sep 22, 2025
The Molecular and Functional Landscape of Resistance to FOLFIRI Chemotherapy in Metastatic Colorectal Cancer.

Marco Avolio, Simonetta M Leto, Francesco Sassi

|Jul 29, 2025
Risk Factors for Arterial Thromboembolic Events in Male Germ Cell Tumors Treated with Chemotherapy.

Daniele Frisone, Melinda Charrier, Grégoire Berthod

|Jul 15, 2025
Modeling oxaliplatin resistance in colorectal cancer reveals a SERPINE1-based gene signature (RESIST-M) and therapeutic strategies for pro-metastatic CMS4 subtype.

Stephen Qi Rong Wong, Mohua Das, Kenzom Tenzin

Pageof 4

Frequent Collaborators

6 joint publications

Sabine Tejpar

3 joint publications

Pratyaksha Wirapati

3 joint publications

Owen J Sansom

3 joint publications

Rachel A Ridgway